Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-Furaldehyde → 5-(Benzoxazol-2-yl)-2-(furan-3-yl)-1-(tetrahydropyran-4-yl)benzimidazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-Furaldehyde | HCID 10351 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | Potassium hydroxy sulfite | HCID 23707502 | — |
| 반응물 | 5-(Benzoxazol-2-yl)-2-(tetrahydropyran-4-yl)aminoaniline | HCID 67498806 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 5-(Benzoxazol-2-yl)-2-(furan-3-yl)-1-(tetrahydropyran-4-yl)benzimidazole | HCID 49821459 | 69% |
반응 단계
To a solution of 5-(benzoxazol-2-yl)-2-(tetrahydropyran-4-yl)aminoaniline (see Working Example 20-2) (200 mg, 0.646 mmol) in dimethylformamide (2 mL) was added 3-furaldehyde (80.7 mg, 0.840 mmol) and oxone (258 mg, 0.420 mmol), and this was stirred at room temperature for 3 hours. After the reaction was complete, aqueous potassium carbonate solution was added, this was filtered and washed with water. The crystals obtained were purified by silica gel column chromatography to yield the title compound (171 mg, 69% yield) as pale yellow crystals.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08829035B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-3654201990e44b268913e761ca02e6fd |
| 출처 메모 | uspto-grants-2014_09 |